Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories (Q36540629)

14 August 2017

1 reference

title

Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories (English)

1 reference

14 August 2017

Caldecott-Hazard S

1

1 reference

14 August 2017

DeLeon-Jones F

3

1 reference

14 August 2017

S. Caldecott-Hazard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1685032

28 October 2022

D. G. Morgan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1685032

28 October 2022

F. DeLeon-Jones

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1685032

28 October 2022

D. H. Overstreet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1685032

28 October 2022

D. Janowsky

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1685032

28 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1685032

28 October 2022

publication date

1 December 1991

1 reference

full work available at URL

14 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002/syn.890090404

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

https://onlinelibrary.wiley.com/doi/full/10.1002/syn.890090404

28 October 2022

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

1 reference

14 August 2017

volume

9

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

251-301

1 reference

Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The basis for amine hypotheses in affective disorders. A critical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Second messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The cholinergic rapid eye movement sleep induction test with RS-86. State or trait marker of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Effects of phenoxybenzamine, aceperone and clonidine on the level of 3-methoxy-4-hydroxyphenylglycol (MOPEG) in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Norepinephrine in depressive reactions. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The "switch process" in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

High-dose naloxone infusions in normals. Dose-dependent behavioral, hormonal, and physiological responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Neuroendocrine responses to intravenous tryptophan in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

beta-Adrenoceptor agonists enhance 5-hydroxytryptamine-mediated behavioural responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Depression and MHPG excretion. Response to dextroamphetamine and tricyclic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Platelet alpha 2-adrenergic receptors in major depressive disorder. Binding of tritiated clonidine before and after tricyclic antidepressant drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Biochemical and functional evidence of supersensitive platelet alpha 2-adrenoceptors in major affective disorder. Effect of long-term lithium carbonate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Antagonistic Effects of Physostigmine and Methylphenidate in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Acetylcholine and Depression*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Beta-endorphin--induced changes in schizophrenic and depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

3-Methoxy-4-hydroxy phenylglycol (MHPG) excretion in depressive states. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Catecholamine Metabolism, Depressive Illness, and Drug Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

beta-Endorphin/beta-lipotropin immunoreactivity in endogenous depression. Effect of dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Brain biogenic amine depletion and mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Homovanillic and 5-Hydroxyindoleacetic Acid in Cerebrospinal Fluid of Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Cellular localization of tyrosine hydroxylase by immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Effects of amitriptyline and imipramine on amine metabolites in the cerebrospinal fluid of depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Effects of a dopamine agonist piribedil in depressed patients: relationship of pretreatment homovanillic acid to antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Alpha 2-adrenergic receptor function in depression. The cortisol response to yohimbine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The diurnal variation in plasma homovanillic acid level persists but the variation in 3-methoxy-4-hydroxyphenylglycol level is abolished under constant conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The catecholamine hypothesis of affective disorders: a review of supporting evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Glycol metabolites of noradrenaline in brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Initial clinical trial based on biochemical methodology of zimelidine (a serotonin uptake inhibitor) in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/dopaminergic interactions in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Urinary 3-methoxy-4-hydroxyphenylglycol circadian rhythm. Early timing (phase-advance) in manic-depressives compared with normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Three cases of manic symptoms following yohimbine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Cholinergic regulation of mood and REM sleep: potential model and marker of vulnerability to affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

5-Hydroxytryptophan-induced cortisol response and CSF 5-HIAA in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Plasma Immunoreactive β-Endorphin Levels in Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Higher CSF levels of HVA and 5-HIAA in delusional compared to nondelusional depression

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Psychosis associated with clonidine withdrawal

28 October 2022

2

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The assessment of abnormalities in hormonal responsiveness at multiple levels of the hypothalamic-pituitary-adrenocortical axis in depressive illness

28 October 2022

8

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents

28 October 2022

9

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Fluoride-stimulated adenylate cyclase activity in rat brain following chronic treatment with psychotropic drugs

28 October 2022

10

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Effect of electroconvulsive treatment on cerebral opioid receptors in the rat: changes in delta but not mu receptors

28 October 2022

14

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients

28 October 2022

16

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

CSF monoamine metabolites in melancholia

28 October 2022

18

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Muscarinic receptor subclassification and G-proteins: significance for lithium action in affective disorders and for the treatment of the extrapyramidal side effects of neuroleptics

28 October 2022

19

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

3-Methoxy-4-hydroxyphenylglycol sulfate, a new metabolite of epinephrine and norepinephrine

28 October 2022

20

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue

28 October 2022

21

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system

28 October 2022

22

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy.

28 October 2022

24

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Development of β-adrenergic receptor subsensitivity by antidepressants

28 October 2022

25

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists

28 October 2022

26

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Noradrenergic innervation of serotonergic neurons in the dorsal raphe: Demonstration by electron microscopic autoradiography

28 October 2022

27

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites

28 October 2022

29

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Imipramine alters beta-adrenergic, but not serotonergic, mediated responses in rat hippocampal pyramidal cells

28 October 2022

31

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline

28 October 2022

32

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

CSF monoamine metabolites in depression and schizophrenia

28 October 2022

34

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Quantitative autoradiographic analysis of the effects of electroconvulsive shock on serotonin-2 receptors in male and female rats

28 October 2022

38

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Interaction of tricyclic antidepressants with opiate receptors

28 October 2022

39

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Serotonin 5-HT2 receptor binding on blood platelets--a peripheral marker for depression?

28 October 2022

40

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Rapid changes in GABA binding induced by stress in different areas of the rat brain

28 October 2022

41

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Electrolytes in urine in endogenous depression

28 October 2022

42

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

[18F]setoperone: a new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo

28 October 2022

47

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Daily variations of the urine content of 3-methoxy-4-hydroxyphenylglycol in two manic-depressive patients.

28 October 2022

49

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The molecular basis of muscarinic receptor diversity

28 October 2022

50

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Effect of GABAergic drugs in the behavioral 'despair' test in rats

28 October 2022

51

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Binding of yohimbine and imipramine to platelets in depressive illness

28 October 2022

52

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

β-endorphin and β-lipotropin plasma levels in chronic schizophrenia, primary affective disorders and secondary affective disorders

28 October 2022

54

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty

28 October 2022

55

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Evidence that serotonin has a role in brain function

28 October 2022

56

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

Pharmacological Reviews

57

11

48

Brodie

1959

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The Journal of Biochemistry

28 October 2022

58

254

7548

Brostrom

1979

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Down-regulation of beta-adrenergic receptors following repeated injections of desmethylimipramine: permissive role of serotonergic axons

28 October 2022

60

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Does platelet serotonin receptor supersensitivity accompany endogenous depression?

28 October 2022

61

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Peptide transmitters: a unifying hypothesis for euphoria, respiration, sleep, and the action of lithium

28 October 2022

67

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Olfactory projection systems, drugs and behaviour: A review

28 October 2022

69

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Limbic postictal events: anatomical substrates and opioid receptor involvement

28 October 2022

70

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Clinical and biochemical aspects of depressive disorders: I. Introduction, classification, and research techniques

28 October 2022

71

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Cerebral correlates of depressed behavior in rats, visualized using 14C-2-deoxyglucose autoradiography.

28 October 2022

72

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease

28 October 2022

73

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The effects of chronic regimens of clorgyline and pargyline on monoamine metabolism in the rat brain

28 October 2022

74

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists

28 October 2022

75

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

SEASONAL AND CIRCADIAN MONOAMINE VARIATIONS IN HUMAN BRAINS EXAMINED POST MORTEM

28 October 2022

76

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Cholinergic mechanisms in the control of behavior by the brain

28 October 2022

77

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Long-term lithium treatment selectively reduces receptor-coupled inositol phospholipid hydrolysis in rat brain

28 October 2022

80

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique

28 October 2022

82

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the α-antagonist piperoxane

28 October 2022

83

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Catecholamine receptors on locus coeruleus neurons: Pharmacological characterization

28 October 2022

84

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Supersensitivity of central noradrenergic presynaptic autoreceptors following chronic treatment with the antidepressant mianserin

28 October 2022

85

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Brain 5-HT2 receptor binding sites in depressed suicide victims

28 October 2022

87

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Brain GABAA/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims

28 October 2022

88

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Serotonin concentrations and turnover in brains of depressed suicides

28 October 2022

89

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Repeated tricyclic antidepressants induce a progressive 'switch' in the electrophysiological response of dopamine neurons to autoreceptor stimulation

28 October 2022

90

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Repeated tricyclics induce a progressive dopamine autoreceptor subsensitivity independent of daily drug treatment

28 October 2022

91

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

94

19

825

Cohen

1984

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Changes in α- and β-receptor densities in rat brain as a result of treatment with monoamine oxidase inhibiting antidepressants

28 October 2022

97

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The biochemistry of affective disorders

28 October 2022

99

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

5-Hydroxytryptamine (5-HT) in the whole-blood of patients with depressive illness

28 October 2022

101

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

A role for 5-HT in the action of antidepressant drugs.

28 October 2022

102

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment

28 October 2022

104

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Evaluation of a proposed hamster separation model of depression

28 October 2022

106

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The pharmacological and anatomical substrates of the amphetamine response in the rat

28 October 2022

108

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Presynaptic Alpha-Receptor Subsensitivity After Long-Term Antidepressant Treatment

28 October 2022

109

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Brain GABAB binding sites in depressed suicide victims

28 October 2022

112

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Chronic antidepressant treatment increases enkephalin levels in n. accumbens and striatum of the rat.

28 October 2022

117

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Hypoalgesia induced by antidepressants in mice: a case for opioids and serotonin

28 October 2022

118

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Antidepressant action of imipramine and iprindole in mice is enhanced by inhibitors of enkephalin-degrading peptidases

28 October 2022

119

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Urinary Catecholamine Metabolites during Behavioral Changes in a Patient with Manic-Depressive Cycles

28 October 2022

121

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Diagnostic subgroups of affective disorders and their urinary excretion of catecholamine metabolities

28 October 2022

122

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin

28 October 2022

125

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants.

28 October 2022

126

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra

28 October 2022

128

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Naloxone inhibits clomipramine in mouse forced swimming test

28 October 2022

129

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Activation of an inhibitory noradrenergic pathway projecting from the locus coeruleus to the cingulate cortex of the rat.

28 October 2022

130

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Cholinergic mechanisms in depression

28 October 2022

131

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

EEG lateral asymmetries in psychiatric disorders

28 October 2022

132

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

134

10

933

Dismukes

1974

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

British Journal of Pharmacology

28 October 2022

136

59

513

Drew

1977

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

139

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

A genetic study of manic-depressive disorder among the old order Amish of Pennsylvania

28 October 2022

141

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Seasonal variation of platelet serotonin uptake and 3H-imipramine binding in normal and depressed subjects

28 October 2022

142

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats

28 October 2022

143

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives

28 October 2022

146

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

β-Endorphin-Like Immunoreactivity in Cerebrospinal Fluid and Plasma of Patients with Schizophrenia and Other Neuropsychiatric Disorders

28 October 2022

147

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Influence of naloxone and methysergide on the analgesic effect of clomipramine in rats

28 October 2022

148

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Measurement of 3H-serotonin uptake in blood platelets in major depressive episodes

28 October 2022

149

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Pain relief by antidepressants: possible modes of action

28 October 2022

151

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Postmortem neurochemical studies in depression

28 October 2022

152

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Increased intracranial self-stimulation in rats after long-term administration of desipramine

28 October 2022

153

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Cholinergic modulation of adrenergic arousal in the developing rat.

28 October 2022

154

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Clinical antidepressant activity of cyclazocine-a narcotic antagonist

28 October 2022

155

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Behavior during hippocampal microinfusions. II. Muscarinic locomotor activation.

28 October 2022

156

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Noradrenaline inhibits depolarization-induced 3H-serotonin release from slices of rat hippocampus

28 October 2022

158

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Chemical coding of neurons and plurichemical transmission

28 October 2022

163

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Studies on the cellular localization and distribution of glucocorticoid receptor and estrogen receptor immunoreactivity in the central nervous system of the rat and their relationship to the monoaminergic and peptidergic neurons of the brain

28 October 2022

165

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Clinical and treatment effects on 3H-clonidine and 3H-imipramine binding in elderly depressed patients

28 October 2022

169

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Catecholamine systems as the neural substrate for intracranial self-stimulation: a hypothesis

28 October 2022

170

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

beta-Endorphin. Intravenous infusion causes behavioral change in psychiatric inpatients

28 October 2022

172

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls

28 October 2022

173

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Moonlighting house officers

28 October 2022

174

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

Clonidine in mania

175

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Diurnal variation of urinary MHPG in unipolar and bipolar depressives

28 October 2022

176

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Characterization of the inducible serotonin-sensitive dihydroalprenolol binding sites with low affinity for isoproterenol

28 October 2022

179

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

5-HT and 5-HIAA in cerebrospinal fluid in depression

28 October 2022

180

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

GABA levels in cerebrospinal fluid of patients with Huntington's chorea: A preliminary report

28 October 2022

181

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Chronic electroconvulsive shock and neurotransmitter receptors--an update

28 October 2022

182

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

INHIBITION OF UPTAKE OF TRITIATED-NORADRENALINE IN THE INTACT RAT BRAIN BY IMIPRAMINE AND STRUCTURALLY RELATED COMPOUNDS.

28 October 2022

183

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in the mouse cortex has pharmacological characteristics compatible with mediation via 5-HT2 receptors but this response does not reflect altered 5-HT2 function after 5,7-dihydroxytrypta

28 October 2022

185

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

GABA levels in CSF of patients with psychiatric disorders

28 October 2022

186

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1)

28 October 2022

188

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Effects of acute and chronic administration of antidepressant drugs on the central cholinergic nervous system. Comparison with anticholinergic drugs

28 October 2022

189

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Behavioral evidence for beta-adrenoceptor subsensitivity after subacute antidepressant/alpha 2-adrenoceptor antagonist treatment

28 October 2022

190

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Thyrotropin nyctohemeral pattern in primary depression: differences between unipolar and bipolar women

28 October 2022

191

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Presynaptic serotonin receptor-mediated response in mice attenuated by antidepressant drugs and electroconvulsive shock

28 October 2022

195

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Alpha-adrenoceptor-mediated modulation of 5-hydroxytryptamine release from rat brain cortex slices

28 October 2022

197

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Characterization of the receptor subtype involved in alpha-adrenoceptor-mediated modulation of serotonin release from rat brain cortex slices

28 October 2022

198

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter

28 October 2022

199

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Serotonin function in affective disorders

28 October 2022

200

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Human platelet 5-hydroxytryptamine receptors: binding of [3H]-lysergic acid diethylamide (LSD). Effects of chronic neuroleptic and antidepressant drug administration

28 October 2022

201

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Noradrenergic denervation prevents sensitization of rat forebrain neurons to serotonin by tricyclic antidepressant treatment

28 October 2022

202

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

(−)-Propranolol inhibits the behavioural responses of rats to increased 5-hydroxytryptamine in the central nervous system

28 October 2022

204

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Catecholamine metabolism in affective disorders. II. Norepinephrine, normetanephrine, epinephrine, metanephrine, and VMA excretion in hypomanic patients

28 October 2022

207

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: effects of suicide

28 October 2022

208

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Direct adrenergic and cholinergic stimulation of hypothalamic mechanisms

28 October 2022

209

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Adenylate cyclase activation by the .beta.-adrenergic receptors as a diffusion-controlled process

28 October 2022

211

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Psychoendocrine model of depression

28 October 2022

213

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Monoamine transport in depression: kinetics and dynamics

28 October 2022

214

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Variations in platelet 5-hydroxytryptamine in control and depressed populations.

28 October 2022

216

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Platelet 5-HT uptake in delusional and nondelusional depressions

28 October 2022

217

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis

28 October 2022

220

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups

28 October 2022

221

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Studies on norepinephrine-containing afferents to Purkinje cells of rat cerebellum. II. Sensitivity of Purkinje cells to norepinephrine and related substances administered by microiontophoresis

28 October 2022

222

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Endogenous opioids and their receptors. Evidence for involvement in the postictal effects of electroconvulsive shock

28 October 2022

223

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Systemic Cholinergic Agents Induce Seizures and Brain Damage in Lithium-Treated Rats

28 October 2022

224

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Repeated electroconvulsive shocks and the brain content of endorphins

28 October 2022

225

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Differences between sodium-dependent and desipramine-defined [3H]imipramine binding in intact human platelets

28 October 2022

226

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Differentiation of two components of specific [3H]imipramine binding in rat brain

28 October 2022

227

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Net effect of acute administration of desipramine on the locus coeruleus — hippocampal system

28 October 2022

229

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The time course of noradrenergic pre- and postsynaptic activity during chronic desipramine treatment

28 October 2022

230

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

231

33

657

Humphreys

1988

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Differential 3H-imipramine platelet binding in patients with panic disorder and depression

28 October 2022

232

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Hormone receptor modulates the regulatory component of adenylyl cyclase by reducing its requirement for Mg2 and enhancing its extent of activation by guanine nucleotides

28 October 2022

233

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Role of Serotonergic Input in the Regulation of the β-Adrenergic Receptor-Coupled Adenylate Cyclase System

28 October 2022

235

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

A cholinergic-adrenergic hypothesis of mania and depression

28 October 2022

238

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Kinetic values of active serotonin transport by platelets of bipolar, unipolar and schizophrenic patients at 2 and at 8 a.m. Preliminary report

28 October 2022

243

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

246

15

45

Jimerson

1980

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Effects of desipramine and yohimbine on α2- and β-adrenoreceptor sensitivity

28 October 2022

248

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The effect of bicuculline, metrazol, picrotoxin and strychnine on the release of ( 3 H)GABA from rat brain slices

28 October 2022

249

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

British Journal of Pharmacology

28 October 2022

250

90

125p

Joly

1987

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Enhancement of 5-hydroxytryptamine-induced behavioral effects following chronic administration of antidepressant drugs

28 October 2022

251

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Characterization of lithium potentiation of pilocarpine-induced status epilepticus in rats

28 October 2022

253

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Acetylcholine content in rat brain is elevated by status epilepticus induced by lithium and pilocarpine

28 October 2022

254

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Antimanic effect of clonidine

28 October 2022

255

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Effects of naloxone-HCl on cortisol levels in patients with affective disorder and normal controls

28 October 2022

256

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Acute Effects of the Synthetic Analogue of Methionine Enkephalin FK 33-824 on Depressive Symptoms*

28 October 2022

257

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Antagonism of endogenous CRH systems attenuates stress-induced freezing behavior in rats

28 October 2022

260

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

261

9

619

Kalisker

1974

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

262

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens

28 October 2022

263

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

264

17

877

Kasa

1982

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Muscarinic binding in suicides

28 October 2022

267

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression

28 October 2022

268

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Failure to confirm muscarinic receptors on skin fibroblasts

28 October 2022

270

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

272

17

14

Kent

1980

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

Pharmacological Reviews

274

17

101

Klerman

1965

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Chronic treatment with antidepressants decreases the number of [3H]SCH 23390 binding sites in the rat striatum and limbic system

28 October 2022

275

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

Pharmacological Reviews

280

16

179

Kopin

1964

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Disposition and Metabolism of MHPG in Humans: Application to Studies in Depression

28 October 2022

281

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Stimulation and destruction of the locus coeruleus: opposite effects on 3-methoxy-4-hydroxyphenylglycol sulfate levels in the rat cerebral cortex

28 October 2022

282

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Alterations in turnover and endogenous levels of norepinephrine in cerebral cortex following electrical stimulation and acute axotomy of cerebral noradrenergic pathways

28 October 2022

283

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis

28 October 2022

284

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Interactions of pharmacological agents which alter biogenic amine metabolism and depression--an analysis of contributing factors within a primate model of depression

28 October 2022

287

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Cerebrospinal fluid measures of neurotransmitter changes associated with pharmacological alteration of the despair response to social separation in rhesus monkeys

28 October 2022

288

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Advances in biochemical psychopharmacology

28 October 2022

289

21

203

Langer

1980

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Substituted tetrahydro-β-carbolines are possible candidates as endogenous ligand of the [3H]Imipramine recognition site

28 October 2022

290

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Serotonin nerve terminals in the locus coeruleus of adult rat: A radioautographic study

28 October 2022

291

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The striatal cholinergic interneuron: synaptic target of dopaminergic terminals?

28 October 2022

292

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Detection of a novel serotonin receptor subtype (5-HT1E) in human brain: interaction with a GTP-binding protein

28 October 2022

297

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Reduced platelet serotonin in depression

28 October 2022

298

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Studies on the role of brain cholinergic systems in the therapeutic mechanisms and adverse effects of ECT and lithium

28 October 2022

299

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

5-HT1A receptor function in depression: effect of chronic amitriptyline treatment

28 October 2022

301

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The effect of chronic lithium pretreatment on rat brain muscarinic receptor regulation

28 October 2022

302

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Norepinephrine in the paraventricular nucleus stimulates corticosterone release

28 October 2022

304

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Endorphins in human cerebrospinal fluid: Clinical correlations to some psychotic states

28 October 2022

305

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Effects of Antidepressant Treatments on Dopamine Turnover in Depressed Patients

28 October 2022

306

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Clinical studies on norepinephrine metabolism: how to interpret the numbers

28 October 2022

307

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Circadian rhythms of epinephrine and norepinephrine in man.

28 October 2022

308

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Adrenoceptors and the pharmacology of affective illness: a unifying theory

28 October 2022

309

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Adrenergic innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A combined light and electron microscopic immunocytochemical study.

28 October 2022

310

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

A combined light and electron microscopic immunocytochemical method for the simultaneous localization of multiple tissue antigens. Tyrosine hydroxylase immunoreactive innervation of corticotropin releasing factor synthesizing neurons in the paravent

28 October 2022

311

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study

28 October 2022

312

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Ultrastructural localization of glucocorticoid receptor (GR) in hypothalamic paraventricular neurons synthesizing corticotropin releasing factor (CRF).

28 October 2022

313

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The potential use of GABA agonists in psychiatric disorders: Evidence from studies with progabide in animal models and clinical trials1

28 October 2022

315

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

316

65

159

Lloyd

1987

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The gabaergic hypothesis of depression

28 October 2022

317

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Journal of neural transmission

28 October 2022

318

29

p13

Lloyd

1990

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Excretion of catecholamine metabolites following intraventricular injection of 6-hydroxydopamine in the Macaca speciosa

28 October 2022

322

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

3-Methoxy-4-Hydroxyphenethyleneglycol Production by Human Brain in Vivo

28 October 2022

323

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Catecholamine metabolism and disposition in healthy and depressed subjects

28 October 2022

325

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

beta-Adrenergic regulation of alpha 2-adrenergic receptors in the central nervous system

28 October 2022

327

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Differential effects of antidepressant treatment on brain monoaminergic receptors

28 October 2022

328

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Opiate antagonists and long-term analgesic reaction induced by inescapable shock in rats

28 October 2022

330

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Chronic treatment with antidepressant drugs: Potentiation of apomorphine-induced aggressive behaviour in rats

28 October 2022

331

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The effect of repeated administration of antidepressant drugs on the responsiveness of rats to catecholamine agonists

28 October 2022

332

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Trazodone, a central serotonin antagonist and agonist

28 October 2022

333

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Aberrant seasonal variations of platelet serotonin uptake in endogenous depression

28 October 2022

334

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

5,7-Dihydroxytryptamine-induced lesions of serotonergic neurons and desipramine-induced down-regulation of cortical beta adrenoceptors: a re-evaluation

28 October 2022

335

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Serotonin-2 binding sites in human frontal cortex and hippocampus. Selective loss of S-2A sites with age.

28 October 2022

340

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

"Specific" binding of [3H]imipramine to protease-sensitive and protease-resistant sites

28 October 2022

341

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

342

30

137

Marcusson

1986

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants.

28 October 2022

343

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Noradrenaline inhibits central serotonin release through alpha 2-adrenoceptors located on serotonergic nerve terminals

28 October 2022

345

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

5-HT receptor binding in post-mortem brain from patients with affective disorder

28 October 2022

346

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Non-selectivity of amitriptyline for subtypes of brain muscarinic receptors demonstrated in binding and functional assays

28 October 2022

347

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Effects of chronic desipramine treatment on rat brain noradrenergic responses to α-adrenergic drugs

28 October 2022

348

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Alterations in tyrosine hydroxylase activity elicited by raphe nuclei lesions in the rat locus coeruleus: evidence for the involvement of serotonin afferents

28 October 2022

349

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

[3H]adrenaline release from hypothalamic synaptosomes and its modulation by clonidine: effects of chronic antidepressant drug regimens

28 October 2022

350

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Postdexamethasone plasma cortisol and beta-endorphin levels in depression: relationship to severity of illness

28 October 2022

351

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

High affinity binding of 3H-paroxetine and 3H-imipramine to rat neuronal membranes

28 October 2022

352

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

3H-imipramine binding sites in platelets from psychiatric patients.

28 October 2022

353

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

α1-adrenoceptor-mediated responses in the lateral geniculate nucleus are enhanced by chronic antidepressant treatment

28 October 2022

357

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Chronic antidepressant treatment enhances alpha-adrenergic and serotonergic responses in the facial nucleus

28 October 2022

358

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Chronic antidepressant treatment enhances agonist affinity of brain alpha 1-adrenoceptors

28 October 2022

359

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Guanosine triphosphate activation of brain adenylate cyclase: enhancement by long-term antidepressant treatment

28 October 2022

360

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Human brain receptor alterations in suicide victims

28 October 2022

361

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Circadian rhythm of serotonin transport in human platelets

28 October 2022

363

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Serotonin uptake by platelets of suicidal and aggressive adolescent psychiatric inpatients

28 October 2022

364

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Mianserin, danitracen and amitriptyline withdrawal increases the behavioural responses of rats to L-5-HTP.

28 October 2022

365

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Personality factors predisposing to depression correlate significantly negatively with M1-muscarinic and beta-adrenergic receptor densities on blood cells

28 October 2022

366

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Contamination of serotonin-2 binding sites by an alpha-1 adrenergic component in assays with (3H) spiperone

28 October 2022

368

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

alpha 1- and alpha 2-adrenoceptors in rat cerebral cortex: effect of frontal lobotomy

28 October 2022

369

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Ciba Foundation Symposium

28 October 2022

371

123

106

Murphy

1986

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Blood cells as biological trait markers in affective disorders

28 October 2022

373

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Clinical relevance of endorphins in psychiatry

28 October 2022

375

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Muscarinic cholinergic receptors on skin fibroblasts in familial affective disorder

28 October 2022

377

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Repeated electroconvulsive shock downregulates the opioid receptors in rat brain

28 October 2022

378

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

β-Adrenergic-Sensitive Adenylate Cyclase in Secretory Cells of Choroid Plexus

28 October 2022

379

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Pharmacological effects of paroxetine after repeated administration to animals

28 October 2022

380

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The role of corticotropin-releasing factor in the pathogenesis of major depression

28 October 2022

381

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

28 October 2022

382

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Effects of cholinergic agonists and antagonists on self-stimulation behavior in the rat

28 October 2022

383

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Modulation of second messenger function in rat brain by in vivo alteration of receptor sensitivity: relevance to the mechanism of action of electroconvulsive therapy and antidepressants

28 October 2022

384

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Down-regulation of beta-adrenoceptors in rat cortex by repeated administration of desipramine, electroconvulsive shock and clenbuterol requires 5-HT neurones but not 5-HT.

28 October 2022

385

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Selective interaction of tricyclic antidepressants with a subclass of rat brain cholinergic muscarinic receptors

28 October 2022

386

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Plasma immunoreactive β-endorphin in dexamethasone suppressors and non-suppressors of cortisol

28 October 2022

388

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Bromocriptine treatment of depressive disorders. Clinical and biochemical effects

28 October 2022

389

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Measuring cholinergic sensitivity: I. Arecoline effects in bipolar patients

28 October 2022

392

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. A cross-over study

28 October 2022

393

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Biochemical aspects

28 October 2022

394

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Reduced sensitivity of neurons to noradrenaline after chronic treatment with antidepressant drugs

28 October 2022

395

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls

28 October 2022

396

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Fatty acids as modulators of membrane functions: catecholamine-activated adenylate cyclase of the turkey erythrocyte

28 October 2022

397

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Coupling of catecholamine receptor from one cell with adenylate cyclase from another cell by cell fusion

28 October 2022

398

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Interaction of beta-adrenoceptor agonists with the serotonergic system in rat brain. A behavioral study using the L-5-HTP syndrome

28 October 2022

399

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Selective breeding for increased cholinergic function: development of a new animal model of depression.

28 October 2022

400

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Selective breeding for diisopropyl fluorophosphate-sensitivity: behavioural effects of cholinergic agonists and antagonists

28 October 2022

403

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Selective breeding for sensitivity to the anticholinesterase DFP

28 October 2022

404

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Selective breeding for differences in cholinergic function: pre- and postsynaptic mechanisms involved in sensitivity to the anticholinesterase, DFP

28 October 2022

405

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Enhanced elevation of corticosterone following arecoline administration to rats selectively bred for increased cholinergic function.

28 October 2022

406

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Stress-induced immobility in rats with cholinergic supersensitivity

28 October 2022

407

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Genetic and pharmacological models of cholinergic supersensitivity and affective disorders

28 October 2022

408

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Antidepressant effects of rolipram in a genetic animal model of depression: cholinergic supersensitivity and weight gain

28 October 2022

410

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Brain 5-HT-2 receptors and suicide

28 October 2022

411

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Effects of neurohumoral and adrenergic agents on cyclic AMP levels in various areas of the rat brain in vitro

28 October 2022

413

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Endogenous opioids and social behavior

28 October 2022

414

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition

28 October 2022

417

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Enhanced benzodiazepine responsiveness in rats with increased cholinergic function

28 October 2022

419

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures

28 October 2022

420

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding

28 October 2022

421

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain

28 October 2022

423

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue

28 October 2022

425

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Decreased imipramine binding in the brains of patients with depressive illness.

28 October 2022

426

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Long-Term Treatment with Lithium Prevents the Development of Dopamine Receptor Supersensitivity

28 October 2022

427

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Plasma GABA in affective illness. A preliminary investigation

28 October 2022

429

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Manic-depressive states and daily temperature. Some circadian studies

28 October 2022

430

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed patients

28 October 2022

433

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

3H-Rauwolscine binding in platelets from depressed patients and healthy volunteers

28 October 2022

435

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The effects of antidepressants and electroconvulsive shocks on the functioning of the mesolimbic dopaminergic system: a behavioral study.

28 October 2022

436

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Behavioral evidence for alpha 1-adrenoceptor up- and alpha 2-adrenoceptor down-regulation in the rat hippocampus after chronic desipramine treatment

28 October 2022

437

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors

28 October 2022

438

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Noradrenergic rather than GABAergic processes as the common mediation of the antidepressant profile of GABA agonists and imipramine-like drugs in animals

28 October 2022

439

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Behavioural despair in rats: A new model sensitive to antidepressant treatments

28 October 2022

440

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Central Norepinephrine Metabolism in Affective Illness: MHPG in the Cerebrospinal Fluid

28 October 2022

442

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites

28 October 2022

445

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Chronic treatment with some atypical antidepressants increases the brain level of 3-methoxy-4-hydroxyphenylglycol (MHPG) in rats

28 October 2022

450

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Platelet MAO deamination of serotonin in depressed patients. Changes after imipramine treatment and clinical correlations

28 October 2022

451

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The regulatory subunit of adenylate cyclase interacts with cytoskeletal components

28 October 2022

452

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Photoaffinity identification of colchicine-solubilized regulatory subunit from rat brain adenylate cyclase

28 October 2022

453

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

A kinetic analysis and replication of decreased platelet serotonin uptake in depressed patients

28 October 2022

454

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Amitriptyline: Long-term treatment elevates α-adrenergic and muscarinic receptor binding in mouse brain

28 October 2022

455

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro

28 October 2022

458

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

459

17

1071

Risch

1982

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Cholinergic challenges in affective illness: behavioral and neuroendocrine correlates

28 October 2022

460

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Ascending catecholamine pathways and amphetamine-induced locomotor activity: Importance of dopamine and apparent non-involvement of norepinephrine

28 October 2022

461

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Serotonergic anxiolytics and treatment of depression

28 October 2022

462

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with ( )-amphetamine: a microdialysis study in freely moving rats.

28 October 2022

463

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The effect of imipramine and lithium on α- and β-receptor binding in rat brain

28 October 2022

464

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents

28 October 2022

465

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Relative activity of metabolic pathways for norepinephrine in endogenous depression

28 October 2022

468

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Urinary excretion of free tyramine and of norepinephrine and its metabolites in unipolar depressed patients

28 October 2022

469

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Urinary monoamines and monoamine metabolites in subtypes of unipolar depressive disorder and normal controls

28 October 2022

470

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Platelet tritiated imipramine binding and serotonin uptake in depressed patients and controls. Relationship to plasma cortisol levels before and after dexamethasone administration

28 October 2022

471

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Selective breeding for sensitivity to DFP: generalization of effects beyond criterion variables

28 October 2022

473

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Stress down-regulates corticosterone receptors in a site-specific manner in the brain

28 October 2022

476

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response

28 October 2022

477

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Decreased plasma serotonin in melancholic patients: A study with clomipramine

28 October 2022

478

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Differential effects of monoamine oxidase inhibitors and serotonin reuptake inhibitors on 3H-serotonin receptor binding in rat brain

28 October 2022

479

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

3-methoxy-4-hydroxyphenylglycol sulfate in brain and cerebrospinal fluid

28 October 2022

481

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Biogenic Amines and Emotion

28 October 2022

485

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine

28 October 2022

486

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Effects of tricyclic antidepressants on the uptake and metabolism of intracisternally administered norepinephrine-H3 in rat brain

28 October 2022

487

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

MHPG excretion in depressive disorders: relation to clinical subtypes and desynchronized sleep

28 October 2022

488

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Species dependence of adaptations at the pre- and postsynaptic serotonergic receptors following long-term antidepressant drug treatment

28 October 2022

491

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Characterization of serotonin receptors and lack of effect of antidepressant therapy on monoamine functions in various regions of the rabbit brain

28 October 2022

492

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications

28 October 2022

493

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Modulation of receptor mechanisms in the CNS: Hyper-and hyposensitivity to catecholamines

28 October 2022

495

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Behavioral activation of rats during intraventricular infusion of norepinephrine

28 October 2022

497

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Learned helplessness in the rat

28 October 2022

498

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity

28 October 2022

499

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Complex inhibition of [3H]imipramine binding by serotonin and nontricyclic serotonin uptake blockers

28 October 2022

501

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity

28 October 2022

503

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

3-Methoxy-4-hydroxyphenylglycol in depression

28 October 2022

504

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Evidence that Lithium Alters Phosphoinositide Metabolism: Chronic Administration Elevates Primarily d-myo-Inositol-1-Phosphate in Cerebral Cortex of the Rat

28 October 2022

505

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Acetylcholine and the regulation of REM sleep: basic mechanisms and clinical implications for affective illness and narcolepsy

28 October 2022

507

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Increased REM sleep in rats selectively bred for cholinergic hyperactivity

28 October 2022

508

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Dopamine Receptor Stimulation in the Treatment of Depression: Piribedil (ET-495)

28 October 2022

510

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Catecholamines and affective disorders revised: a critical assessment

28 October 2022

511

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Interaction of reserpine, serotonin, and lysergic acid diethylamide in brain

28 October 2022

513

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

514

19

131

Siever

1984

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Antidepressants and alpha 2-adrenergic autoreceptor desensitization

28 October 2022

515

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression

28 October 2022

516

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Platelet alpha-adrenergic binding and biochemical responsiveness in depressed patients and controls

28 October 2022

517

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Cholinergic and adrenergic interaction in the hypothalamic control of drinking and eating behavior

28 October 2022

518

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

The association of supersensitive cholinergic REM-induction and affective illness within pedigrees

28 October 2022

520

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Metabolism of 5-Hydroxytryptamine (Serotonin) by Monoamine Oxidase

28 October 2022

522

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Femoxetine and amitriptyline in general practice: a randomized double-blind group comparison

28 October 2022

523

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

alpha 2-Adrenoreceptors in rat brain are decreased after long-term tricyclic antidepressant drug treatment

28 October 2022

525

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Activation of specific central dopamine pathways: locomotion and footshock

28 October 2022

526

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Clonidine-induced sedation in rats: evidence for mediation by postsynaptic alpha 2-adrenoreceptors

28 October 2022

527

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Platelet alpha 2-adrenergic receptor sensitivity in major depressive disorder

28 October 2022

528

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Increased serotonin-2 binding sites in frontal cortex of suicide victims

28 October 2022

530

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Tritiated imipramine binding sites are decreased in the frontal cortex of suicides

28 October 2022

531

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Inhibition of adrenergic neurotransmission by clonidine: an action on prejunctional -receptors.

28 October 2022

532

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Involvement of alpha-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones

28 October 2022

533

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Preferential blockade of presynaptic α-adrenoceptors by yohimbine

28 October 2022

534

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Reciprocal adrenergic and cholinergic control of hypothalamic elicited eating and satiety

28 October 2022

535

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Electroconvulsive shock decreases beta-adrenoceptors despite serotonin lesions

28 October 2022

536

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Adrenocortical activation in alcoholics during chronic drinking

28 October 2022

537

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Humoral changes in manic-depressive psychosis with particular reference to the excretion of catechol amines in urine

28 October 2022

539

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Journal of Biological Chemistry

28 October 2022

540

256

2105

Su

1980

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Role of biogenic amines in certain pathological conditions

28 October 2022

541

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Changes in rat brain monoamine turnover following chronic antidepressant administration

28 October 2022

542

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning

28 October 2022

543

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

New perspectives on the molecular pharmacology of affective disorders

28 October 2022

545

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Mode of action of antidepressant drugs

28 October 2022

548

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Corticotropin releasing factor produces behavioural activation in rats

28 October 2022

549

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Effect of chronic imipramine or baclofen on GABA-B binding and cyclic AMP production in cerebral cortex

28 October 2022

550

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Feedback Inhibition of Brain Noradrenaline Neurons by Tricyclic Antidepressants: α-Receptor Mediation

28 October 2022

551

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study

28 October 2022

552

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Delusional versus non-delusional depression: Neurochemical differences

28 October 2022

553

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Regulation of glucocorticoid receptors in brain by corticosterone treatment of adrenalectomized rats

28 October 2022

557

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Serotonergic function and suicidal behavior in personality disorders

28 October 2022

558

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Problems in the organization and control of acetylcholine synthesis in brain neurons

28 October 2022

561

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

3H-catecholamine binding to α-receptors in rat brain: Enhancement by reserpine

28 October 2022

562

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

563

16

47

U'Prichard

1979

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Tricyclic Antidepressants: Therapeutic Properties and Affinity for α-Noradrenergic Receptor Binding Sites in the Brain

28 October 2022

564

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus

28 October 2022

565

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

In search of the mode of action of antidepressants 5-HTP/tyrosine mixtures in depressions

28 October 2022

567

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Indoleamines in depression and suicide

28 October 2022

568

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Therapeutic indications for serotonin-potentiating compounds: a hypothesis

28 October 2022

569

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Evolution of neurotransmitter receptor systems

28 October 2022

572

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Molecular biology of adrenergic and muscarinic cholinergic receptors. A perspective

28 October 2022

573

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders

28 October 2022

574

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain

28 October 2022

575

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Adaptive mechanisms of the noradrenergic cyclic AMP generating system in the limbic forebrain of the rat: adaptation to persistent changes in the availability of norepinephrine (NE)

28 October 2022

576

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

A possible common mechanism of action of antidepressant treatments: reduction in the sensitivity of the noradrenergic cyclic AMP gererating system in the rat limbic forebrain

28 October 2022

577

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Chronic administration of antidepressant drugs increases the density of cortical [3H]prazosin binding sites in the rat.

28 October 2022

578

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Human corticotropin releasing hormone: clinical studies in patients with affective disorders, alcoholism, panic disorder and in normal controls

28 October 2022

579

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Dysbalance of neuronal second messenger function in the aetiology of affective disorders: a pathophysiological concept hypothesising defects beyond first messenger receptors

28 October 2022

580

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Absence of anticholinergic activity of rolipram, an antidepressant with a novel mechanism of action, in three different animal models in vivo

28 October 2022

581

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Bromocriptine and imipramine in endogenous depression. A double-blind controlled trial in out-patients

28 October 2022

582

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Noradrenergic Transmission in Depression: Under- or Overfunction?

28 October 2022

583

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Antagonism by antidepressants of serotonin S1 and S2 receptors of normal human brain in vitro

28 October 2022

586

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Do antidepressants induce dopamine autoreceptor subsensitivity?

28 October 2022

863

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment

28 October 2022

595

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Cerebrospinal Fluid Levels of MHPG in Affective Disorders

28 October 2022

598

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Catecholamine theories of reward: A critical review

28 October 2022

599

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br-LSD.

28 October 2022

601

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

In vivo inhibition of liver and brain monoamine oxidase by 1-Isonicotinyl-2-isopropyl hydrazine.

28 October 2022

604

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

Serotonin (5-HT) uptake by blood platelets in anorexia nervosa

28 October 2022

605

1 reference

https://api.crossref.org/works/10.1002/SYN.890090404

28 October 2022

Identifiers

1 reference

release_7rjbaozt3ve7rnzgc6tni56see

14 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7rjbaozt3ve7rnzgc6tni56see

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference